An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
2 Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.
3 Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
4 VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
5 Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
1 Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
2 Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.
3 Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
4 VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
5 Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395:1014–1015.
-
PMC
-
PubMed
Siu K-L, Yuen K-S, Castano-Rodriguez C. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865–8877.
-
PMC
-
PubMed
Cavalli G, De Luca G, Campochiaro C. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:e325–e331.
-
PMC
-
PubMed
Geleris J, Sun Y, Platt J. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2012410. published online May 7.
-
DOI
-
PMC
-
PubMed
Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260–1280.
-
PMC
-
PubMed